M. Forman

发表

Hypothyroidism and Parkinson's disease and the issue of diagnostic confusion

J. Trojanowski, G. Baltuch, T. Simuni, 2003, Movement disorders : official journal of the Movement Disorder Society.

Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration

B. Miller, J. Trojanowski, M. Gorno-Tempini, 2008, American journal of Alzheimer's disease and other dementias.

Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration

J. Trojanowski, V. Lee, M. Forman, 2005, The Journal of Neuroscience.

Impaired Glutamate Transport in a Mouse Model of Tau Pathology in Astrocytes

J. Trojanowski, V. Lee, M. Forman, 2006, The Journal of Neuroscience.

Delivery of human vascular endothelial growth factor with platinum coils enhances wall thickening and coil impregnation in a rat aneurysm model.

S. Diamond, M. Forman, M. Grady, 2001, AJNR. American journal of neuroradiology.

Frontotemporal lobar degeneration: demographic characteristics of 353 patients.

B. Miller, J. Neuhaus, Hans Förstl, 2005, Archives of neurology.

Frontotemporal dementia progresses to death faster than Alzheimer disease

K Yaffe, B L Miller, J Q Trojanowski, 2005, Neurology.

Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia.

Jennifer Farmer, Murray Grossman, Anjan Chatterjee, 2007, Archives of neurology.

Frontotemporal dementia: Clinicopathological correlations

Jennifer Farmer, Murray Grossman, Anjan Chatterjee, 2006, Annals of neurology.

Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations.

J. Trojanowski, M. Grossman, C. Clark, 2007, Archives of neurology.

Proteasome Inhibition Stabilizes Tau Inclusions in Oligodendroglial Cells that Occur after Treatment with Okadaic Acid

J. Trojanowski, V. Lee, M. Forman, 2003, The Journal of Neuroscience.

Genotypically Defined Lissencephalies Show Distinct Pathologies

J. Golden, M. Forman, W. Dobyns, 2005, Journal of neuropathology and experimental neurology.

Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.

J. Trojanowski, D. Dickson, V. Lee, 2005, Journal of neuropathology and experimental neurology.

‘Unfolding’ pathways in neurodegenerative disease

John Q Trojanowski, J. Trojanowski, V. Lee, 2003, Trends in Neurosciences.

Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations

J. Trojanowski, V. Lee, N. Cairns, 2007, Annals of neurology.

The Novel BACE Inhibitor MK-8931 Dramatically Lowers CSF A Peptides in Healthy Subjects: Results from a Rising Single Dose Study (PL02.004)

M. Forman, J. Wagner, S. Ramael, 2012 .

The novel BACE inhibitor MK-8931 dramatically lowers CSF beta-amyloid in patients with mild-to-moderate Alzheimer's disease

M. Forman, L. Ereshefsky, O. Laterza, 2013, Alzheimer's & Dementia.

Biodegradable polyglycolide endovascular coils promote wall thickening and drug delivery in a rat aneurysm model.

S. Diamond, M. Forman, M. Grady, 2001 .

Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons.

J. Trojanowski, V. Lee, M. Forman, 2001, Experimental neurology.

Fatal subacute cytomegalovirus encephalitis associated with hypogammaglobulinemia and thymoma.

S. Kasner, M. Forman, B. Cucchiara, 2003, Mayo Clinic proceedings.

Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia

Charles D. Smith, S. Mehta, M. Forman, 2008, American journal of medical genetics. Part A.

TDP‐43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations

N. Cairns, W. Markesbery, M. Forman, 2007, Journal of neuropathology and experimental neurology.

Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.

J. Trojanowski, V. Lee, M. Forman, 1997, The American journal of pathology.

Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies

J. Trojanowski, M. Grossman, C. Clark, 2008, Journal of neuropathology and experimental neurology.

TDP-43: a novel neurodegenerative proteinopathy

J. Trojanowski, V. Lee, M. Forman, 2007, Current Opinion in Neurobiology.

Frontotemporal lobar degeneration with motor neuron disease: a clinical and pathological spectrum.

C. Clark, M. Forman, 2006, Archives of neurology.

From Progressive Nonfluent Aphasia to Corticobasal Syndrome: A Case Report of Corticobasal Degeneration

M. Gorno-Tempini, M. Forman, R. Sánchez-Valle, 2006, Neurocase.

Neurodegenerative Diseases: Frontotemporal dementia with parkinsonism linked to Chromosome 17

J. Trojanowski, V. Lee, M. Forman, 2005 .

Multiple pathologies in a patient with a progressive neurodegenerative syndrome

J. Trojanowski, A. Siderowf, M. Forman, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Differential Effects of the Swedish Mutant Amyloid Precursor Protein on β-Amyloid Accumulation and Secretion in Neurons and Nonneuronal Cells*

R. Doms, M. Forman, V. Lee, 1997, The Journal of Biological Chemistry.

VCP Mutations Causing Frontotemporal Lobar Degeneration Disrupt Localization of TDP-43 and Induce Cell Death*

A. Goate, N. Cairns, M. Forman, 2009, Journal of Biological Chemistry.

Hereditary tauopathies and idiopathic frontotemporal dementias

J. Trojanowski, V. Lee, M. Esiri, 2004 .

Hemangiopericytoma of the third ventricle. Case report.

M. Forman, E. Lavi, J. Abrahams, 1999, Journal of neurosurgery.

mechanism with frontotemporal dementia muscle suggests a common pathogenic TDP-43 accumulation in inclusion body myopathy

Sara E. Miller, P. Hanson, M. Forman, 2009 .

17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.

M. Weiner, H. Feiler, J. Trojanowski, 2004, Archives of neurology.

TDP-43 Mediates Degeneration in a Novel Drosophila Model of Disease Caused by Mutations in VCP/p97

J. Trojanowski, V. Lee, Brian D. Freibaum, 2010, The Journal of Neuroscience.

BIOSYNTHESIS OF APP AND Aβ: MULTIPLE PATHWAYS FOR THE GENERATION OF INTRACELLULAR Aβ

R. Doms, M. Forman, V. Lee, 1998 .

Retinal findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (cadasil).

S. Galetta, M. Forman, L. Balcer, 2001, Survey of ophthalmology.

Role for Akt3/protein kinase Bgamma in attainment of normal brain size.

T. Ludwig, M. Birnbaum, M. Forman, 2005, Molecular and cellular biology.

Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia

J. Trojanowski, M. Grossman, V. Lee, 2010, Neurology.

CSF biomarkers in frontotemporal lobar degeneration with known pathology

J. Trojanowski, M. Grossman, C. Clark, 2008, Neurology.

Advanced Conservation Strategies Maximizing Return on Investments for Island Restoration with a Focus on Seabird Conservation Innovative. Self Sustaining. Economically Efficient. a Report Prepared for the Commonweal Ocean Policy Program Recommended Citation C. Josh Donlan and Burr Heneman. 2007. Max

J. Waring, E. Siemers, H. Soares, 2022 .

Efficacy of a disinfectant wipe method for the removal of adenovirus 8 from tonometer tips.

J. Froggatt, M. Forman, O. Schein, 1993, Ophthalmology.

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

J. Trojanowski, M. Forman, L. Golbe, 2003, Science.

Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease.

Qin Jiang, William J Greenlee, Xia Chen, 2016, Journal of medicinal chemistry.

The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts

A. Myers, J. Trojanowski, J. Karlawish, 2007, Neurobiology of Disease.

New insights into genetic and molecular mechanisms of brain degeneration in tauopathies

J. Trojanowski, V. Lee, M. Forman, 2000, Journal of Chemical Neuroanatomy.

Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs

John Q Trojanowski, J. Trojanowski, V. Lee, 2004, Nature Medicine.

Role for Akt3/Protein Kinase Bγ in Attainment of Normal Brain Size

T. Ludwig, M. Birnbaum, M. Forman, 2005, Molecular and Cellular Biology.

Safety, Tolerability, and Pharmacokinetics of the β‐Site Amyloid Precursor Protein‐Cleaving Enzyme 1 Inhibitor Verubecestat (MK‐8931) in Healthy Elderly Male and Female Subjects

M. Forman, M. Troyer, J. Palcza, 2019, Clinical and translational science.

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients

Michael Tanen, Matthew E. Kennedy, Wei Li, 2016, Science Translational Medicine.

Recommended Citation

J. Waring, E. Siemers, H. Soares, 1998 .

Superficial Siderosis of the Cns Associated with Multiple Cavernous Malformations Address Reprint Requests To

E. Thaler, M. Forman, L. Loevner, 2022 .

Biodegradable Polyglycolide Endovascular Coils Promote Wall Thickening and Drug Delivery in a Rat Aneurysm Model

S. Diamond, M. Forman, M. Grady, 2001, Neurosurgery.

Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK‐8931) in Healthy Japanese Adults: A Randomized, Placebo‐Controlled Study

Michael Tanen, M. Forman, M. Vugt, 2019, Clinical pharmacology and therapeutics.

TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.

J. Morris, J. Trojanowski, V. Lee, 2007, The American journal of pathology.

Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy

J. Taylor, M. Forman, G. P. Ritson, 2007, Acta Neuropathologica.

Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells

R. Doms, T. Iwatsubo, M. Forman, 1997, Nature Medicine.

Alzheimer’s Disease, Parkinson’s Disease, and Frontotemporal Dementias: Different Manifestations of Protein Misfolding

J. Trojanowski, V. Lee, M. Forman, 2008 .

Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man

Steven V. Fox, J. Renger, P. Coleman, 2016, Scientific Reports.

Symptomatic lateral ventricular ependymal cysts: criteria for distinguishing these rare cysts from other symptomatic cysts of the ventricles: case report.

M. Forman, D. O’Rourke, J. Boockvar, 2000, Neurosurgery.

TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia

A. Pestronk, P. Hanson, M. Forman, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Novel Ubiquitin Neuropathology in Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations

Charles D. Smith, J. Karlawish, A. Pestronk, 2006, Journal of neuropathology and experimental neurology.

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development

Eric E. Smith, David S. Miller, R. Petersen, 2016, Alzheimer's & dementia.

Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration

A Chatterjee, J Q Trojanowski, X Wang, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies

J. Trojanowski, V. Lee, E. Kremmer, 2009, Acta Neuropathologica.

Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles

R. Vandenberghe, G. Bormans, E. Hostetler, 2018, The Journal of Nuclear Medicine.

Axonal Degeneration Induced by Targeted Expression of Mutant Human Tau in Oligodendrocytes of Transgenic Mice That Model Glial Tauopathies

Bin Zhang, John Q Trojanowski, Makoto Higuchi, 2005, The Journal of Neuroscience.

Retarded Axonal Transport of R406W Mutant Tau in Transgenic Mice with a Neurodegenerative Tauopathy

Bin Zhang, John Q Trojanowski, Makoto Higuchi, 2004, The Journal of Neuroscience.

An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter

J. Waring, E. Siemers, H. Soares, 2015, Alzheimer's Research & Therapy.

Cognitive and motor assessment in autopsy-proven corticobasal degeneration

J. Trojanowski, M. Gorno-Tempini, M. Grossman, 2007, Neurology.

Tau and α-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam

J. Trojanowski, D. Perl, V. Lee, 2002 .

Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam.

J. Trojanowski, D. Perl, V. Lee, 2002, The American journal of pathology.

Amyotrophic Lateral Sclerosis/Parkinsonism Dementia Complex: Transgenic Mice Provide Insights into Mechanisms Underlying a Common Tauopathy in an Ethnic Minority on Guam

Bin Zhang, John Q. Trojanowski, Makoto Higuchi, 2002, Experimental Neurology.

Genotype-phenotype correlations in FTDP-17: does form follow function?

M. Forman, 2004, Experimental Neurology.

Signature tau neuropathology in gray and white matter of corticobasal degeneration.

Murray Grossman, John Q Trojanowski, J. Trojanowski, 2002, The American journal of pathology.

Palatability and Swallowability of Pimavanserin When Mixed with Selected Food Vehicles: An Exploratory Open-Label Crossover Study

M. Forman, C. Zamora, A. Kouassi, 2021, Geriatrics.

Biochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individual

J. Trojanowski, A. Chatterjee, M. Grossman, 2007, Acta Neuropathologica.

Longitudinal decline in autopsy-defined frontotemporal lobar degeneration

X. Wang, J. Trojanowski, H. Coslett, 2008, Neurology.

TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions.

Murray Grossman, Peachie Moore, John Q Trojanowski, 2007, Archives of neurology.

Nosology of Parkinson’s Disease: Looking for the Way Out of a Quackmire

J. Trojanowski, V. Lee, M. Forman, 2005, Neuron.

Co-occurrence of Parkinson's disease with progressive supranuclear palsy

J. Trojanowski, D. Hinkle, V. Lee, 2002, Acta Neuropathologica.

Prominent Perikaryal Expression of α- and β-Synuclein in Neurons of Dorsal Root Ganglion and in Medullary Neurons

J. Trojanowski, V. Lee, M. Forman, 2001, Experimental Neurology.

Cortical biochemistry in MCI and Alzheimer disease

S. Leurgans, J. Trojanowski, V. Lee, 2007, Neurology.

Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology.

J. Trojanowski, V. Lee, M. Forman, 2004, The American journal of pathology.

Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report.

Gordon H Baltuch, John Q Trojanowski, J. Trojanowski, 2004, Journal of neurosurgery.

Frontotemporal lobar degeneration: demographic characteristics of 353 patients.

J. Neuhaus, Hans Förstl, A. Kurz, 2005, Archives of neurology.

Consistency of BACE inhibitor-mediated brain amyloid production inhibition by MK-8931 in Alzheimer’s disease patients and healthy young adults

M. Forman, J. Palcza, J. Stone, 2013, Alzheimer's & Dementia.

Safety and pharmacokinetics of the novel BACE inhibitor MK-8931 in healthy subjects following single- and Multiple-Dose administration

M. Forman, L. Ereshefsky, J. Wagner, 2012, Alzheimer's & Dementia.

The novel BACE inhibitor MK-8931 dramatically lowers cerebrospinal fluid Aβ peptides in healthy subjects following single- and multiple-dose administration

M. Forman, L. Ereshefsky, O. Laterza, 2012, Alzheimer's & Dementia.

Differential effects of the swedish mutant amyloid precursor protein on beta-amyloid accumulation and secretion in neurons and nonneuronal cells.

R. Doms, M. Forman, V. Lee, 1998, The Journal of biological chemistry.